All GEMSTAR Family of Infusers; GemStar Infusion System - Single Therapy; GemStar 7 Therapy Infusion System 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Hospira Pty Limited 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2013-RN-00247-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2013-04-12
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • 데이터 추가 비고
  • 원인
    The proximal and distal pressure sensor calibration can drift resulting in late or missed or false occlusion alarms or reporting of one of the following errors during device setup or infusion:- cassette check – d- cassette check – p- proximal occlusion- distal occlusion- pressure calibration error- bad pressure sensor event- bad pressure sensor state- distal pressure is out of range- proximal sensor is out of range.
  • 조치
    Hospira recommends customers to review the GemStar maintenance schedule and confirm that the Operation test (which includes specific tests for proximal and distal occlusion) is being performed at least on an annual basis. If a device fails either of the proximal or distal occlusion tests at any time immediately remove it from clinical service and return it to and return it to Hospira for repair. Hospira is in consultation with TGA for any further action. Healthcare professionals are advised to weigh the risk/benefit to patients associated with the use of the device when administering critical therapies. Customers should consider the use of an alternative pump, particularly in patients in which delay/interruption in therapy or under/over infusion could result in significant injury or death.

Device

  • 모델명 / 제조번호(시리얼번호)
    All GEMSTAR Family of Infusers; GemStar Infusion System - Single Therapy; GemStar 7 Therapy Infusion SystemGemStar Infusion System - Single TherapyCatalogue Number: 611308801Number on Pump: 13088 / 13150GemStar 7 Therapy Infusion SystemCatalogue Number: 611308701Number on Pump: 13087 / 13000
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DHTGA